RICH TYVIN (Chief Medical Officer) sold 36.8% of their position (1.41K shares) of SHUTTLE PHARMACEUTICALS HOLDINGS, INC. on the open market
Open‑market sale worth $2.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/3/2023ACC: 0001493152-23-000014
Officer· Chief Medical Officer
Since Aug 2022
-1.41K
Net shares
Net seller
$2.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.41K disposed
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
−1.41K
Price / share
$1.60
Trade value
$2.27K
% of position
36.8%
12/29/2022
3.84K→2.43K
Total
Net shares
−1.41K
Net value
-$2.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 12/29/2022 | S · Sale | −1.41K | $1.60 | $2.27K | 36.8% | 3.84K | 2.43K |
| Total | −1.41K | -$2.27K | ||||||
Derivative Transactions0
No derivative transactions reported